SMITH STAN purchased 5.5% of their position (66.67K shares) of MAIA BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $100.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/12/2025ACC: 0001127602-25-013963
+133.33K
Net shares
Net buyer
$100.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
133.33K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+66.67K
Price / share
$1.50
Trade value
$100K
% of position
5.5%
5/8/2025
1.21M→1.27M
Total
Net shares
+66.67K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/8/2025 | P · Purchase | +66.67K | $1.50 | $100K | 5.5% | 1.21M | 1.27M |
| Total | +66.67K | $100K | ||||||
Derivative Transactions1
Warrants
Indirect
Converts to
Common Stock
66.67K shares
Shares
+66.67K
Strike price
2.05
Held after
66.67K
Exercisable
—
5/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Indirect | Common Stock66.67K shares | 5/8/2025 | P · Purchase | +66.67K | 2.05 | — | 66.67K |